{"id":12674,"date":"2019-03-22T12:57:26","date_gmt":"2019-03-22T17:57:26","guid":{"rendered":"https:\/\/www.sprim.com\/post\/sprims-quarterly-ventures-day-meeting-in-new-york\/"},"modified":"2019-03-22T13:13:27","modified_gmt":"2019-03-22T18:13:27","slug":"sprims-quarterly-ventures-day-meeting-in-new-york","status":"publish","type":"post","link":"https:\/\/www.sprim.com\/pt-br\/post\/sprims-quarterly-ventures-day-meeting-in-new-york\/","title":{"rendered":"SPRIM&#8217;s Quarterly Ventures Day Meeting in New York"},"content":{"rendered":"<p style=\"margin-bottom: 12.0pt;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">SPRIM, in partnership with Tikehau Capital, is hosting its&nbsp;<\/span><a href=\"https:\/\/inbound.sprim.com\/investor-day-nyc?utm_campaign=Investor%20Day&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz-9qeX69jVoM10qTqZCVFAEDtI---rKJm1pE8KrTzixdgKzDsAmwOhHuBRdE53SdSgKT6C4G\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif;\">quarterly Ventures Day meeting<\/span><\/a><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&nbsp;on April 24, and for the first time, the event will take place in New York.&nbsp;<\/span><\/p>\n<p style=\"margin-bottom: 12.0pt;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">This one-day meeting will provide&nbsp;unique insights into&nbsp;trends in biotech and digital health innovations.<\/span><\/p>\n<p style=\"margin-bottom: 12.0pt;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">The following companies will have 30 minutes each to demonstrate how they are transforming the healthcare landscape. You will hear about:<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Obvio Health\u2019s<\/span><\/strong>&nbsp;technology to digitize and revolutionize the clinical trial process from recruitment to reporting.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Travecta Therapeutics\u2019&nbsp;<\/span><\/strong>novel Blood-Brain Barrier transport platform to develop a pipeline of drugs that treat disorders of the central nervous system.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Vanteres\u2019&nbsp;<\/span><\/strong>commitment to developing lipid nutraceuticals for improving human health.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Fibronostics\u2019&nbsp;<\/span><\/strong>algorithm-based digital diagnostics for early disease detection.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Objective GI\u2019s<\/span><\/strong>&nbsp;cutting-edge capabilities for connecting doctors and patients to research opportunities.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">Evid Science\u2019s<\/span><\/strong>&nbsp;use of AI to unlock insights from medical literature.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">1nHealth\u2019s&nbsp;<\/span><\/strong>transformational approach to subject recruitment for clinical trials.<\/span><\/p>\n<p style=\"margin: 5.0pt 0in 12.0pt .5in;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&#8211;<strong><span style=\"font-family: 'Arial',sans-serif;\">RegASK\u2019s<\/span><\/strong>&nbsp;NLP technology for making regulatory knowledge more accessible.<\/span><\/p>\n<p style=\"margin-bottom: 12.0pt;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">We would love to see you at&nbsp;<strong><span style=\"font-family: 'Arial',sans-serif;\">NeueHouse, on April 24<sup>th<\/sup>&nbsp;from 8:30 a.m. to 3 p.m<\/span><\/strong>.<\/span><\/p>\n<p style=\"margin-bottom: 12.0pt;\"><span style=\"font-size: 11.5pt; font-family: 'Arial',sans-serif; color: #444444;\">&nbsp; <a class=\"button\" href=\"https:\/\/inbound.sprim.com\/investor-day-nyc\">Confirm Your Attendance<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SPRIM Ventures in partnership with Tikehau Capital is hosting a Ventures Day event in New York on April 24.  &#8230; <a class=\"read-more\" href=\"https:\/\/www.sprim.com\/pt-br\/post\/sprims-quarterly-ventures-day-meeting-in-new-york\/\">Read More&nbsp;<i class=\"fas fa-angle-double-right\" style=\"display: inline\"><\/i><\/a><\/p>\n","protected":false},"author":17,"featured_media":12671,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":""},"categories":[300,301],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts\/12674"}],"collection":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/comments?post=12674"}],"version-history":[{"count":0,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/posts\/12674\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/media\/12671"}],"wp:attachment":[{"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/media?parent=12674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/categories?post=12674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sprim.com\/pt-br\/wp-json\/wp\/v2\/tags?post=12674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}